2017-2022 United States Drugs for Schistosomiasis Market Report (Status and Outlook)

March 2017 | 119 pages | ID: 2CE984749ABEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Drugs for Schistosomiasis market size will be XX million (USD) in 2022 in United States, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) XX% from 2016 to 2022.

In United States market, the top players include many company. With key sales data like sales (volume), revenue, market share for top players.such as

• Shin Poong
• Merck
• Bayer
• EIPICO
• Chandra Bhagat Pharma
• Taj Pharmaceuticals

Split by product types/category, covering many types. with sales, revenue and market share for each type, such as

• Praziquantel
• Oxamniquine
• Other

Split by applications/end use industries, covers many application. This report focuses on sales, market share and growth rate of Drugs for Schistosomiasis in each application.suach as

• S. haematobium
• S. mansoni
• S. japonicum
• S. mekongi
• S. intercalatum

Contents

1 DRUGS FOR SCHISTOSOMIASIS MARKET OVERVIEW

1.1 Product Overview and Scope of Drugs for Schistosomiasis
1.2 Drugs for Schistosomiasis Market Segment by Types
  1.2.1 United States Drugs for Schistosomiasis Sales Present Situation and Outlook by Types (2012-2022)
  1.2.2 United States Drugs for Schistosomiasis Sales Market Share by Types in 2016
  1.2.3 Praziquantel
  1.2.4 Oxamniquine
Other
1.3 United States Drugs for Schistosomiasis Market Segment by Applications/End Use Industries
  1.3.1 United States Drugs for Schistosomiasis Sales Present Situation and Outlook by Applications/End Industrials (2012-2022)
  1.3.2 United States Drugs for Schistosomiasis Sales Market Share by Types in 2016
  1.3.3 S. haematobium
  1.3.4 S. mansoni
  1.3.5 S. japonicum
  1.3.6 S. mekongi
S. intercalatum
1.4 United States Drugs for Schistosomiasis Overview and Market Size (Value) (2012-2022)
  1.4.1 United States Market Drugs for Schistosomiasis Overview
  1.4.2 United States Drugs for Schistosomiasis Market Size (Value and Volume) Status and Forecast (2012-2022)

2 UNITED STATES DRUGS FOR SCHISTOSOMIASIS SALES, REVENUE (VALUE) AND MARKET SHARE BY VENDORS/MANUFACTURERS

2.1 United States Drugs for Schistosomiasis Sales and Market Share (2012-2017) by Vendors/Manufacturers
2.2 United States Drugs for Schistosomiasis Revenue and Market Share by Vendors (2012-2017)
2.3 United States Drugs for Schistosomiasis Average Price by Vendors in 2016
2.4 United States Drugs for Schistosomiasis Manufacturing Base Distribution, Sales Area, Product Types by Vendors
2.5 Drugs for Schistosomiasis Market Competitive Situation and Trends
  2.5.1 Drugs for Schistosomiasis Market Concentration Rate
  2.5.2 Drugs for Schistosomiasis Market Share of Top 3 and Top 5 Vendors
  2.5.3 Mergers & Acquisitions, Expansion

3 UNITED STATES DRUGS FOR SCHISTOSOMIASIS SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

3.1 United States Drugs for Schistosomiasis Sales, Revenue, Market Share and Price by Type (2012-2017)
  3.1.1 United States Drugs for Schistosomiasis Sales and Market Share by Type (2012-2017)
  3.1.2 United States Drugs for Schistosomiasis Revenue and Market Share by Type (2012-2017)
  3.1.3 United States Drugs for Schistosomiasis Price by Type (2012-2017)
3.2 United States Drugs for Schistosomiasis Sales and Market Share by Application (2012-2017)
3.3 United States Market Drugs for Schistosomiasis Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)

4 UNITED STATES DRUGS FOR SCHISTOSOMIASIS VENDORS/MANUFACTURERS PROFILES AND SALES DATA

4.1 Shin Poong
  4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.1.2 Drugs for Schistosomiasis Product Types, Application and Specification
    4.1.2.1 Category One
    4.1.2.2 Category Two
  4.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.1.4 Main Business/Business Overview
  4.1.5 Shin Poong News
4.2 Merck
  4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.2.2 Drugs for Schistosomiasis Product Types, Application and Specification
    4.2.2.1 Category One
    4.2.2.2 Category Two
  4.2.3 Merck Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.2.4 Main Business/Business Overview
  4.2.5 Merck News
4.3 Bayer
  4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.3.2 Drugs for Schistosomiasis Product Types, Application and Specification
    4.3.2.1 Category One
    4.3.2.2 Category Two
  4.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.3.4 Main Business/Business Overview
  4.3.5 Bayer News
4.4 EIPICO
  4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.4.2 Drugs for Schistosomiasis Product Types, Application and Specification
    4.4.2.1 Category One
    4.4.2.2 Category Two
  4.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.4.4 Main Business/Business Overview
  4.4.5 EIPICO News
4.5 Chandra Bhagat Pharma
  4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.5.2 Drugs for Schistosomiasis Product Types, Application and Specification
    4.5.2.1 Category One
    4.5.2.2 Category Two
  4.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.5.4 Main Business/Business Overview
  4.5.5 Chandra Bhagat Pharma News
4.6 Taj Pharmaceuticals
  4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.6.2 Drugs for Schistosomiasis Product Types, Application and Specification
    4.6.2.1 Category One
    4.6.2.2 Category Two
  4.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2015 and 2016)
  4.6.4 Main Business/Business Overview
  4.6.5 Taj Pharmaceuticals News

5 PRODUCTION COST ANALYSIS OF DRUGS FOR SCHISTOSOMIASIS

5.1 Main Raw Materials of Drugs for Schistosomiasis
  5.1.1 List of Drugs for Schistosomiasis Main Raw Materials
  5.1.2 Drugs for Schistosomiasis Main Raw Materials Price Analysis
  5.1.3 Drugs for Schistosomiasis Raw Materials Major Suppliers
  5.1.4 Drugs for Schistosomiasis Main Raw Materials Market Concentration Rate
5.2 Production Cost Structure of Drugs for Schistosomiasis
  5.2.1 Raw Materials
  5.2.2 Labor Cost
  5.2.3 Production Expenses
5.3 Drugs for Schistosomiasis Manufacturing Process/Method

6 VALUE CHAIN, PURCHASING STRATEGY AND DOWNSTREAM BUYERS

6.1 Drugs for Schistosomiasis Value Chain Analysis
6.2 Upstream Raw Materials Purchasing
6.3 Raw Materials Sources of Drugs for Schistosomiasis Major Vendors in 2016
6.4 Downstream Buyers

7 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

7.1 Sales Channel
  7.1.1 Direct Sales
  7.1.2 Indirect Sales
  7.1.3 Sales Channel Development Trend
7.2 Product Market Positioning
  7.2.1 Pricing Strategy
  7.2.2 Brand Strategy
  7.2.3 Target Client
7.3 Drugs for Schistosomiasis Distributors/Traders List in United States

8 MARKET INFLUENCES FACTORS ANALYSIS

8.1 Changes from the Related Industries
8.2 Substitutes Threat
8.3 Customer Preference Change
8.4 Economic/Political Environmental Change
8.5 Upstream and Downstream Fluctuation

9 UNITED STATES DRUGS FOR SCHISTOSOMIASIS MARKET FORECAST (2017-2022)

9.1 United States Drugs for Schistosomiasis Sales, Revenue and Price Forecast (2017-2022)
  9.1.1 United States Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
  9.1.2 United States Drugs for Schistosomiasis Revenue and Growth Rate Forecast (2017-2022)
  9.1.3 United States Drugs for Schistosomiasis Price Trend Forecast (2017-2022)
9.2 United States Drugs for Schistosomiasis Sales Forecast by Type (2017-2022)
9.3 United States Drugs for Schistosomiasis Sales Forecast by Application (2017-2022)

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Analyst Introduction
11.3 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for Schistosomiasis
Figure United States Drugs for Schistosomiasis Sales (volume) for Each Type (2012-2022)
Figure United States Drugs for Schistosomiasis Sales Market Share by Types in 2016
Figure Product Picture of Praziquantel
Table Major Players of Praziquantel
Figure Product Picture of Oxamniquine
Table Major Players of Oxamniquine
Figure Product Picture of Other
Table Major Players of Other
Figure United States Drugs for Schistosomiasis Sales Present Situation and Outlook by Applications (2012-2022)
Figure United States Drugs for Schistosomiasis Sales Market Share by Types in 2016
Figure S. haematobium Examples
Figure S. mansoni Examples
Figure S. japonicum Examples
Figure S. mekongi Examples
Figure S. intercalatum Examples
Figure United States Drugs for Schistosomiasis Revenue (Million USD) Status and Forecast (2012-2022)
Figure United States Drugs for Schistosomiasis Sales (Volume) Status and Forecast (2012-2022)
Table United States Drugs for Schistosomiasis Sales by Vendors (2012-2017)
Table United States Drugs for Schistosomiasis Sales Market Share (%) by Vendors (2012-2017)
Figure United States Drugs for Schistosomiasis Sales Share by Vendors in 2015
Figure United States Drugs for Schistosomiasis Sales Share by Vendors in 2016
Table United States Drugs for Schistosomiasis Revenue (Million USD) by Vendors (2012-2017)
Table United States Drugs for Schistosomiasis Revenue Market Share (%) by Vendors (2012-2017)
Figure United States Drugs for Schistosomiasis Revenue Share by Vendors in 2015
Figure United States Drugs for Schistosomiasis Revenue Share by Vendors in 2016
Table United States Drugs for Schistosomiasis Average Price by Vendors in 2016
Table United States Drugs for Schistosomiasis Manufacturing Base Distribution and Sales Area by Vendors
Table Vendors Drugs for Schistosomiasis Product Types
Figure Drugs for Schistosomiasis Market Share of Top 3 Vendors
Figure Drugs for Schistosomiasis Market Share of Top 5 Vendors
Table United States Drugs for Schistosomiasis Sales by Type (2012-2017)
Table United States Drugs for Schistosomiasis Sales and Market Share by Type (2012-2017)
Figure United States Drugs for Schistosomiasis Sales Market Share by Type (2012-2017)
Figure 2016 United States Drugs for Schistosomiasis Sales Market Share by Type
Table United States Drugs for Schistosomiasis Revenue (Million USD) by Type (2012-2017)
Table United States Drugs for Schistosomiasis Revenue Market Share by Type (2012-2017)
Figure United States Drugs for Schistosomiasis Revenue Market Share by Type (2012-2017)
Figure 2016 United States Drugs for Schistosomiasis Revenue Market Share by Type
Table United States Drugs for Schistosomiasis Price by Type (2012-2017)
Table United States Drugs for Schistosomiasis Sales by Application (2012-2017)
Table United States Drugs for Schistosomiasis Sales and Market Share by Application (2012-2017)
Figure United States Drugs for Schistosomiasis Sales Market Share by Application (2012-2017)
Figure 2016 United States Drugs for Schistosomiasis Sales Market Share by Application
Table United States Market Drugs for Schistosomiasis Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
Table Shin Poong Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shin Poong Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Shin Poong Drugs for Schistosomiasis Market Share (2012-2017)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Drugs for Schistosomiasis Market Share (2012-2017)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Drugs for Schistosomiasis Market Share (2012-2017)
Table EIPICO Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table EIPICO Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure EIPICO Drugs for Schistosomiasis Market Share (2012-2017)
Table Chandra Bhagat Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Chandra Bhagat Pharma Drugs for Schistosomiasis Market Share (2012-2017)
Table Taj Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Taj Pharmaceuticals Drugs for Schistosomiasis Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Drugs for Schistosomiasis Main Raw Materials Price Trend
Table Drugs for Schistosomiasis Raw Materials Major Suppliers List
Figure Production Cost Structure of Drugs for Schistosomiasis
Figure Drugs for Schistosomiasis Manufacturing Process/Method
Figure Drugs for Schistosomiasis Value Chain Analysis
Table Raw Materials Sources of Drugs for Schistosomiasis Major Vendors in 2016
Table Major Buyers of Drugs for Schistosomiasis
Table Drugs for Schistosomiasis Distributors/Traders List in United States
Figure United States Drugs for Schistosomiasis Sales and Growth Rate Forecast (2017-2022)
Figure United States Drugs for Schistosomiasis Revenue and Growth Rate Forecast (2017-2022)
Figure United States Drugs for Schistosomiasis Price Trend Forecast (2017-2022)
Table United States Drugs for Schistosomiasis Sales Forecast by Type (2017-2022)
Figure United States Drugs for Schistosomiasis Sales Market Share Forecast by Type (2017-2022)
Figure United States Drugs for Schistosomiasis Sales Market Share Forecast by Type in 2022
Table United States Drugs for Schistosomiasis Sales Forecast by Application (2017-2022)
Figure United States Drugs for Schistosomiasis Sales Market Share Forecast by Application (2017-2022)
Figure United States Drugs for Schistosomiasis Sales Market Share Forecast by Application in 2022